Tag: ibrance

Breast Cancer Drugs Linked to Deadly Lung Inflammation

Health officials are warning about rare but severe cases of lung inflammation linked to the breast cancer drugs Ibrance® (palbociclib), Kisqali® (ribociclib), and Verzenio® (abemaciclib).